Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03829579
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2020-02-10
First Post:
2019-02-01
Brief Title:
Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression TRD
Sponsor:
Organization:
Janssen Research Development LLC